Document Detail

Efficacy and safety of itraconazole pulses vs. continuous regimen in cutaneous sporotrichosis.
MedLine Citation:
PMID:  20626531     Owner:  NLM     Status:  In-Data-Review    
Background  Primary observation of using itraconazole pulse regimen (commonly used for onychomycosis) in five sporotrichosis patients produced satisfactory effect, but there are no randomized controlled trials to assess this regimen and to compare with routine continuous regimen. Objectives  The aim of this study was to compare the efficacy and safety of itraconazole pulse regimen, as a new treatment option for cutaneous sporotrichosis, with continuous regimen. Methods  A prospective, randomized, evaluator-blind, controlled study was performed. A total of 50 cutaneous sporotrichosis patients were divided randomly into two groups: Pulsed Rx (n(pulse)  = 25), treated with itraconazole 200 mg b.i.d. for 1 week and off for 3 weeks; Daily Rx (n(cont)  = 25), treated with itraconazole 100 mg bid continuously. In total, 46 patients (n(pulse)  = 22, n(cont)  = 24) were assessable at the end of the study. Cure rates at weeks 12, 24 and 48 along with the course of treatment and the rate of side effects were evaluated. Results  In Pulsed Rx, the cure rates at weeks 12, 24 and 48 were 77.3%, 81.8%, 81.8% respectively. The mean course of treatment was 2.65 ± 0.81 pulses and the rate of side effects was 4.5%; In Daily Rx, the corresponding cure rates were 79.2%, 91.7% and 95.8% respectively. The mean course of treatment was 2.80 ± 2.33 months and the rate of side effects was 16.7%. These parameters had no significant difference between the two groups (P > 0.05). Conclusion  The efficacy and safety of Itraconazole pulse regimen for cutaneous sporotrichosis were similar to the continuous regimen. It is an effective and safe alternative treatment for cutaneous sporotrichosis, which can also lower the cost by decreasing the number of capsules.
Y Song; S-X Zhong; L Yao; Q Cai; J-F Zhou; Y-Y Liu; S-S Huo; S-S Li
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Journal of the European Academy of Dermatology and Venereology : JEADV     Volume:  25     ISSN:  1468-3083     ISO Abbreviation:  J Eur Acad Dermatol Venereol     Publication Date:  2011 Mar 
Date Detail:
Created Date:  2011-02-07     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9216037     Medline TA:  J Eur Acad Dermatol Venereol     Country:  Netherlands    
Other Details:
Languages:  eng     Pagination:  302-5     Citation Subset:  IM    
Copyright Information:
© 2010 The Authors. Journal of the European Academy of Dermatology and Venereology © 2010 European Academy of Dermatology and Venereology.
Department of Dermatology and Venerology, First Hospital of Jilin University, Changchun, Jilin, China.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Reliability and cost-effectiveness of sentinel lymph node excision under local anaesthesia versus ge...
Next Document:  Circumscribed palmo-plantar hypokeratosis: a disease of desquamation? Immunohistological study of fi...